Mackenzie Financial’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.84M | Sell |
8,410
-83
| -1% | -$18.2K | ﹤0.01% | 826 |
|
|
2025
Q1 | $1.9M | Buy |
8,493
+929
| +12% | +$208K | ﹤0.01% | 802 |
|
|
2024
Q4 | $2.48M | Buy |
7,564
+634
| +9% | +$208K | ﹤0.01% | 718 |
|
|
2024
Q3 | $2.08M | Sell |
6,930
-399
| -5% | -$120K | ﹤0.01% | 716 |
|
|
2024
Q2 | $2.41M | Sell |
7,329
-318
| -4% | -$105K | ﹤0.01% | 690 |
|
|
2024
Q1 | $3.03M | Buy |
7,647
+270
| +4% | +$107K | ﹤0.01% | 650 |
|
|
2023
Q4 | $2.6M | Sell |
7,377
-7,932
| -52% | -$2.79M | ﹤0.01% | 678 |
|
|
2023
Q3 | $5.65M | Buy |
15,309
+8,043
| +111% | +$2.97M | 0.01% | 523 |
|
|
2023
Q2 | $2.75M | Sell |
7,266
-2,619
| -26% | -$991K | ﹤0.01% | 670 |
|
|
2023
Q1 | $3.42M | Buy |
9,885
+83
| +0.8% | +$28.8K | 0.01% | 624 |
|
|
2022
Q4 | $2.31M | Sell |
9,802
-890
| -8% | -$209K | ﹤0.01% | 649 |
|
|
2022
Q3 | $2.63M | Buy |
10,692
+464
| +5% | +$114K | ﹤0.01% | 637 |
|
|
2022
Q2 | $3.09M | Buy |
10,228
+265
| +3% | +$80.1K | 0.01% | 623 |
|
|
2022
Q1 | $4.09M | Buy |
9,963
+89
| +0.9% | +$36.6K | 0.01% | 616 |
|
|
2021
Q4 | $4.63M | Sell |
9,874
-5,838
| -37% | -$2.74M | 0.01% | 592 |
|
|
2021
Q3 | $6.67M | Buy |
15,712
+6,370
| +68% | +$2.7M | 0.01% | 521 |
|
|
2021
Q2 | $3.36M | Buy |
9,342
+1,260
| +16% | +$453K | ﹤0.01% | 630 |
|
|
2021
Q1 | $2.28M | Buy |
8,082
+1,128
| +16% | +$318K | ﹤0.01% | 666 |
|
|
2020
Q4 | $1.97M | Sell |
6,954
-4,170
| -37% | -$1.18M | ﹤0.01% | 610 |
|
|
2020
Q3 | $3.06M | Buy |
11,124
+1,638
| +17% | +$450K | 0.01% | 481 |
|
|
2020
Q2 | $2.16M | Buy |
9,486
+2,486
| +36% | +$565K | 0.01% | 546 |
|
|
2020
Q1 | $1.07M | Buy |
7,000
+5,594
| +398% | +$852K | ﹤0.01% | 626 |
|
|
2019
Q4 | $211K | Buy |
+1,406
| New | +$211K | ﹤0.01% | 1031 |
|
|
2019
Q1 | – | Sell |
-2,455
| Closed | -$241K | – | 1329 |
|
|
2018
Q4 | $241K | Buy |
2,455
+228
| +10% | +$22.4K | ﹤0.01% | 1070 |
|
|
2018
Q3 | $275K | Buy |
+2,227
| New | +$275K | ﹤0.01% | 1010 |
|